Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
» OPTR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

OPTR Guru Trades in Q1 2013

Paul Tudor Jones Sold Out
Steven Cohen 455,977 sh (-70.77%)
» More
Q2 2013

OPTR Guru Trades in Q2 2013

Louis Moore Bacon 100,000 sh (unchged)
Steven Cohen 102,560 sh (-77.51%)
» More
Q3 2013

OPTR Guru Trades in Q3 2013

Jeremy Grantham 207,000 sh (New)
Paul Tudor Jones 11,000 sh (New)
Mario Gabelli 20,000 sh (New)
Jean-Marie Eveillard 160,100 sh (New)
Louis Moore Bacon 200,000 sh (New)
Steven Cohen Sold Out
» More
Q4 2013

OPTR Guru Trades in Q4 2013

Jeremy Grantham Sold Out
Louis Moore Bacon Sold Out
Jean-Marie Eveillard Sold Out
Paul Tudor Jones Sold Out
Mario Gabelli Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with OPTR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Jean-Marie Eveillard 2013-12-31 Sold Out 0.01%$12.54 - $12.931 $ 12.781%0
Mario Gabelli 2013-12-31 Sold Out $12.54 - $12.931 $ 12.781%0
Jean-Marie Eveillard 2013-09-30 New Buy0.01%$12.47 - $15.59 $ 12.78-4%160100
Mario Gabelli 2013-09-30 New Buy$12.47 - $15.59 $ 12.78-4%20000
George Soros 2011-09-30 Sold Out 0.0017%$6.96 - $16.87 $ 12.7813%0
George Soros 2011-06-30 New Buy$11.82 - $14.51 $ 12.78-2%10200
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

Business Description

Industry: Biotechnology » Biotechnology
Compare:NVO, AMGN, GILD, BIIB, CELG » details
Traded in other countries:XYH.Germany
Optimer Pharmaceuticals, Inc., is a biopharmaceutical company currently focused on commercializing antibiotic product DIFICID (fidaxomicin) in the United States and Canada.
» More Articles for OPTR

Headlines

Articles On GuruFocus.com
Weekly CEO Sells Highlight: Optimer Pharmaceuticals, ReachLocal, Tractor Supply, and RF Industries Apr 14 2013 
Optimer Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
Optimer Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
Optimer Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 04 2010 
Optimer Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2010 
Weekly CEO Buy Highlights: Helix Energy Solutions Group Inc, Optimer Pharmaceuticals Inc, Keithley I Jan 02 2010 
Optimer Pharmaceuticals Inc. (OPTR) COO and SVP Tessie M Che buys 18,000 Shares Dec 29 2009 
Optimer Pharmaceuticals Inc. (OPTR) CEO Michael N Chang buys 18,000 Shares Dec 29 2009 
Weekly CEO Buys Highlight: Optimer Pharmaceuticals Inc, MBIA Inc, Endeavour International Corp, Dana Dec 04 2009 
Weekly CEO Buys Highlight: Prospect Capital Corp, CONSTELLATION ENERGY, Optimer Pharmaceuticals Inc, Nov 30 2009 

More From Other Websites
FDA approves Cubist antibiotic for skin infections Jun 20 2014
FDA approves Cubist antibiotic for skin infections Jun 20 2014
OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Oct 24 2013
Cubist Pharmaceuticals Completes Acquisition of Optimer Pharmaceuticals Oct 24 2013
OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Oct 23 2013
Cubist Pharma Misses on Earnings and Revenues in Q3 Oct 23 2013
OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Other Events Oct 15 2013
Stellar Biotechnologies Appoints Tessie Che, Ph.D. to Board of Directors Sep 25 2013
OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 18 2013
OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Sep 16 2013
OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 13 2013
Hart-Scott-Rodino waiting period expires for Cubist acquisition of Optimer Sep 13 2013
How Cellceutix Acquired A Next Generation Antibiotic For Pennies On The Dollar Sep 12 2013
Cubist Pharma Prices Senior Notes Sep 10 2013
Scientific Conferences Create Buzz And Move Biotech Stocks: Michael King Sep 06 2013
Voluntary Recall at Cubist Pharma Aug 30 2013
OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 22 2013
Still Neutral on Cubist Pharma Aug 20 2013
OPTIMER PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 07 2013
OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 02 2013

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide